Neuropharmacological activities of the aqueous fraction of methanol extract of Securinega virosa (Roxb. ex. Willd) Baill. root bark in mice
Abstract
Securinega virosa (Euphorbiaceae) is a commonly used medicinal plant in the management of epilepsy and mental illnesses. Previously, the anticonvulsant and antipsychotic activities of the methanol root bark extract have been reported. In an attempt to isolate the bioactive principle(s) responsible for these activities, this study was designed to evaluate the anticonvulsant and CNS depressant activities of the aqueous fraction of the root bark extract in mice. The fraction at the dose of 500 mg/kg protected 66.67% of the mice against pentylenetetrazole (PTZ)-induced seizure and prolonged the onset of seizure in unprotected animals. The fraction did not offer significant protection against strychnine and 4-aminopyridine-induced seizures. At all the doses tested (125-500 mg/kg), the fraction significantly (p < 0.05) reduced the number of head dips (in the hole board test), upward stairs climbed and rearings (in the stair case test). In the beam walking assay, the fraction significantly (p < 0.05) increased the number of foot slips. The findings of the study suggested that aqueous fraction of the methanol root bark extract of Securinega virosa possesses anti-PTZ and sedative activities; and further lend credence to the use of the root of the plant in the management of epilepsy and mental illness.
Keywords: Securinega virosa; Epilepsy; Sedatives; Pentylenetetrazole
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email:
